Semler Scientific, Inc.
SMLR
$29.58
-$1.16-3.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -44.44% | -17.56% | -17.19% | -22.25% | -12.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -44.44% | -17.56% | -17.19% | -22.25% | -12.65% |
| Cost of Revenue | -24.86% | 21.23% | 4.05% | 2.95% | -1.73% |
| Gross Profit | -46.11% | -20.05% | -18.74% | -24.02% | -13.47% |
| SG&A Expenses | 21.28% | -13.67% | -14.41% | -23.97% | -27.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.10% | -10.61% | -10.31% | -20.22% | -25.30% |
| Operating Income | -119.37% | -31.00% | -26.57% | -25.49% | 11.51% |
| Income Before Tax | -1,060.23% | 1,057.64% | -8.77% | -85.17% | 17.55% |
| Income Tax Expenses | -689.73% | 339.52% | -48.03% | -36.99% | 3.61% |
| Earnings from Continuing Operations | -1,165.40% | 591.92% | 1.72% | -99.81% | 22.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,165.40% | 591.92% | 1.72% | -99.81% | 22.22% |
| EBIT | -119.37% | -31.00% | -26.57% | -25.49% | 11.51% |
| EBITDA | -118.25% | -30.84% | -27.06% | -25.25% | 10.81% |
| EPS Basic | -865.25% | 486.07% | -3.01% | -99.82% | 18.83% |
| Normalized Basic EPS | -506.44% | 371.50% | -19.88% | -87.47% | 12.47% |
| EPS Diluted | -964.44% | 534.57% | 1.41% | -99.81% | 23.81% |
| Normalized Diluted EPS | -558.88% | 402.58% | -15.47% | -86.91% | 17.38% |
| Average Basic Shares Outstanding | 39.22% | 18.06% | 4.88% | 3.54% | 2.86% |
| Average Diluted Shares Outstanding | 23.30% | 10.76% | -0.60% | -0.91% | -1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |